Zealand Pharma A/S (Nasdaq: ZEAL) today announced that Boehringer Ingelheim has reported that up to …
!["Survodutide Phase 2 Trial Results"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/pexels-photo-2182972.webp?resize=600%2C400&ssl=1)
!["Survodutide Phase 2 Trial Results"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/pexels-photo-2182972.webp?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Zealand Pharma A/S (Nasdaq: ZEAL) today announced that Boehringer Ingelheim has reported that up to …